Search

Current filters:
Add Filter:

Results

Customise results display
Item hits:
Issue DateTitleAuthor(s)
-PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian CancerDickson, K-A; Xie, T; Evenhuis, C; Ma, Y; Marsh, DJ
2016-12-15The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancerDickson, K-A; Cole, AJ; Gill, AJ; Clarkson, A; Gard, GB; Chou, A; Kennedy, CJ; Henderson, BR; Fereday, S; Traficante, N; Alsop, K; Bowtell, DD; deFazio, A; Clifton-Bligh, R; Marsh, DJ
2016-12Host-Guest Complexes of Carboxylated Pillar[n]arenes With Drugs.Wheate, NJ; Dickson, K-A; Kim, RR; Nematollahi, A; Macquart, RB; Kayser, V; Yu, G; Church, WB; Marsh, DJ
2022-09-23Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall SurvivalXie, T; Dickson, K-A; Yee, C; Ma, Y; Ford, CE; Bowden, NA; Marsh, DJ
2021-10-22An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles.Joshi, N; Liu, D; Dickson, K-A; Marsh, DJ; Ford, CE; Stenzel, MH
2022-04-11The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer CellsLiu, D; Kaufmann, GF; Breitmeyer, JB; Dickson, K-A; Marsh, DJ; Ford, CE
2022-02-10Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized MedicineYee, C; Dickson, K-A; Muntasir, MN; Ma, Y; Marsh, DJ
2020-05-26Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways.Cole, AJ; Dickson, K-A; Liddle, C; Stirzaker, C; Shah, JS; Clifton-Bligh, R; Marsh, DJ
Results 1-8 of 8 (Search time: 0.02 seconds).
  • previous
  • 1
  • next